Mesoblast Ltd has released a press release.
Completion of Tasly Transaction, and Appendix 3B
Filed with ASX ·
Watch Mesoblast's latest callMesoblast (ASX:MSB) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mesoblast (ASX:MSB) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Story so far
Earlier from Mesoblast
- Day 180 Survival Outcomes In aGvHD Phase 3 Trial
- Tasly Receives Approvals For Transaction With MSB
- Mesoblast Reports on Annual and Fourth Quarter Results
- Update on tasly transaction
- MSB Enters Into Cardiovascular Alliance For China With Tasly
Later from Mesoblast
- MSB Expands Partnership With JCR For Skin Disease
- LVAD Trial Results Provide Potential Regulatory Pathway
- LVAD Results Webcast Presentation
- Response to ASX query
- P3 Trial of MSBs Cell Therapy in CHF Completes Recruitment
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast